Development of plasma cell tumors during treatment of multiple myeloma

被引:6
作者
Vaiopoulos, G [1 ]
Viniou, N [1 ]
Plata, E [1 ]
Konstantopoulos, K [1 ]
Andreopoulos, A [1 ]
Rombos, Y [1 ]
Meletis, J [1 ]
Loukopoulos, D [1 ]
Yataganas, X [1 ]
机构
[1] UNIV ATHENS,LAIKO GEN HOSP,SCH MED,DEPT INTERNAL MED 1,GR-11527 ATHENS,GREECE
关键词
multiple myeloma; plasmacytoma; alpha-interferon; computerized tomography;
D O I
10.1007/s002770050178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma cell tumors (plasmacytomas-PCT) of the bone, or extramedullary PCT, may be diagnosed in patients with or without the diagnostic criteria for systemic multiple myeloma (MM). The reason for the local development of these tumors is not clear. Recent reports emphasize the contribution of CT and MRI in the detection of bone lesions and their expansion into the soft tissues. We report the development of PCT in nine patients with MM under maintenance treatment with alpha-IFN, of whom six had no evidence of systemic relapse and three had indications of early relapse. The PCT were located in the pelvis (4), thoracic (3), cervical (1), and lumbar (2) spine and in 8/9 cases were not demonstrable on plain X-rays. These observations suggest that frequent screening with advanced imaging techniques may detect local disease expansion in asymptomatic patients. Early application of radiochemotherapy may improve prognosis.
引用
收藏
页码:317 / 320
页数:4
相关论文
共 50 条
  • [31] Treatment of multiple myeloma
    Harousseau, JL
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 130 (44) : 1649 - 1655
  • [32] Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy
    Rios-Tamayo, Rafael
    Martin-Garcia, Agustin
    Alarcon-Payer, Carolina
    Sanchez-Rodriguez, Dolores
    Maria del Valle Diaz de la Guardia, Ana
    Garcia Collado, Carlos Gustavo
    Jimenez Morales, Alberto
    Jurado Chacon, Manuel
    Cabeza Barrera, Jose
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2399 - 2408
  • [33] Tumour kinetics in multiple myeloma before, during, and after treatment
    Lincz, LF
    Crooks, RL
    Way, SL
    Granter, N
    Spencer, A
    LEUKEMIA & LYMPHOMA, 2001, 40 (3-4) : 373 - 384
  • [34] Plasma Cell Immunophenotyping Improve Prognostic Stratification of Multiple Myeloma Patients
    Meddour, Yanis
    Rahali, Momahed Cherif
    Belakehal, Salah Eddine
    Benfenatki, Nacera
    Ardjoune, Fatma Zohra
    Chaib, Samia
    Djidjik, Reda
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2018, 11 (01)
  • [35] Monitoring of plasma cell proliferative and apoptotic indices in the course of multiple myeloma
    Minarik, Jiri
    Scudla, Vlastimil
    Ordeltova, Marta
    Bacovsky, Jaroslav
    Pika, Tomas
    Langova, Katerina
    LEUKEMIA & LYMPHOMA, 2009, 50 (12) : 1983 - 1991
  • [36] Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma
    Dmoszynska, A
    Bojarska-Junak, A
    Domanski, D
    Rolinski, J
    Hus, M
    Soroka-Wojtaszko, M
    LEUKEMIA & LYMPHOMA, 2002, 43 (02) : 401 - 406
  • [37] Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma
    Mellors, Patrick W.
    Binder, Moritz
    Buadi, Francis K.
    Lacy, Martha Q.
    Gertz, Morie A.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kapoor, Prashant
    Gonsalves, Wilson I.
    Hwa, Yi L.
    Fonder, Amie
    Hobbs, Miriam
    Kourelis, Taxiarchis
    Warsame, Rahma
    Zeldenrust, Steven R.
    Lust, John A.
    Leung, Nelson
    Go, Ronald S.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 2960 - 2967
  • [38] Biological research on the occurrence and development of multiple myeloma and its treatment
    Wu, Yue
    Shi, Xiangjun
    Yao, Xinchen
    Du, Xinru
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (05)
  • [39] Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland
    Samaras, Panagiotis
    Bargetzi, Mario
    Betticher, Daniel C.
    Driessen, Christoph
    Duchosal, Michel A.
    Heim, Dominik
    Ketterer, Nicolas
    Lerch, Erika
    Matthes, Thomas
    Mey, Ulrich
    Pabst, Thomas
    Schmidt, Adrian
    Taverna, Christian
    Zander, Thilo
    Renner, Christoph
    SWISS MEDICAL WEEKLY, 2019, 149
  • [40] Dendritic cell vaccines in the treatment of multiple myeloma -: Advances and limitations
    Büchler, T
    Hajek, R
    MEDICAL ONCOLOGY, 2002, 19 (04) : 213 - 218